-
Treatment Combination Improves Survival in EGFR-positive Lung CancerAdding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
-
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
-
From the Editor-in-Chief
Reducing Ovarian Cancer RiskResearchers examine whether removing the fallopian tubes could help prevent ovarian cancer.
by William G. Nelson, MD, PhD
-
Forward Look
A Combination Approach for EGFR-positive Lung CancerTwo targeted therapies used together extend survival for advanced non-small cell lung cancer but come with side effects.
by Darcy Lewis
-
Forward Look
A Safer Way to Prevent Blood ClotsA lower-dose blood thinner reduces bleeding risk while still protecting against blood clots.
by Ashley P. Taylor
-
Forward Look
Reducing Sexual Side Effects From Prostate Cancer SurgeryReal-time tumor analysis offers assurance to surgeons seeking to preserve nerves involved in erectile function.
by Carolyn Bernhardt
-
Forward Look
Improving Breast Cancer Outcomes After SurgeryAntibody-drug conjugate improves survival in people with early-stage HER2-positive breast cancer who have residual disease.
by Susan Kreimer
-
Forward Look
Cancer ‘Fingerprint’ Drives Vaccine DevelopmentA vaccine based on a tumor’s unique genetic mutations leads to lasting immune response in locally advanced kidney cancer.
by Christina Szalinski
-
The HER2 SHIFTAntibody-drug conjugate provides an additional treatment option for people with HER2-low breast cancer.
by Kendall K. Morgan
-
Sound Advice
Does cancer treatment cause skin side effects?Patients often experience redness, itchiness, dryness and rashes, but they can take steps to prepare their skin for treatment.
Adding chemotherapy to targeted therapy improves outcomes for people with advanced EGFR-positive non-small cell lung cancer.
by Sandra Gordon
Lessons From 20 Years Living With CancerMultiple myeloma survivor Jonathan Gluck reflects on uncertainty, and the scientific progress that has kept him living with cancer for more than two decades.
by Eric Fitzsimmons
The Enduring Importance of Cancer Disparities ResearchOpening session from AACR conference highlights how perseverance and adversity have informed cancer disparities research over the years.
by Eric Fitzsimmons
Most Cancer Survivors Don’t Meet Healthy Diet GoalsDespite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
-
Keeping Hope Alive—Why the Schlueters Rally for Medical ResearchRichard and Michelle Schlueter attended the Rally for Medical Research to advocate for NIH funding after budget cuts delayed his treatment.
-
Cancer in the Rearview Mirror: 15 Years of AACR Cancer Progress Report Survivor StoriesCancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives and the progress made against cancer.
Cancer Research at a Crossroads
